Novo Nordisk's pricing techniques in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of value gouging, declaring the stark contrast amongst U.S. costs and people in Europe and copyright. Novo Nordisk is linked to government funded